HFQRX
Price
$8.36
Change
-$0.00 (-0.00%)
Updated
Aug 20 closing price
Net Assets
7.92B
SIDRX
Price
$16.35
Change
+$0.20 (+1.24%)
Updated
Aug 21 closing price
Net Assets
3.78B
Interact to see
Advertisement

HFQRX vs SIDRX

HFQRX vs SIDRX Comparison Chart in %
View a ticker or compare two or three
VS
HFQRX vs. SIDRX commentary
Aug 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HFQRX is a StrongBuy and SIDRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HFQRX has more cash in the bank: 7.92B vs. SIDRX (3.78B). HFQRX pays higher dividends than SIDRX: HFQRX (6.16) vs SIDRX (2.74). HFQRX was incepted earlier than SIDRX: HFQRX (11 years) vs SIDRX (12 years). SIDRX (0.75) is less costly to investors than HFQRX (0.69). HFQRX is a more actively managed with annual turnover of: 175.00 vs. SIDRX (120.00). HFQRX has a lower initial minimum investment than SIDRX: HFQRX (1000000) vs SIDRX (5000000). SIDRX annual gain was more profitable for investors over the last year : 28.54 vs. HFQRX (25.84). SIDRX return over 5 years is better than : 89.02 vs. HFQRX (79.15).
HFQRXSIDRXHFQRX / SIDRX
Total Expense Ratio0.690.7592%
Annual Report Gross Expense Ratio0.690.7592%
Fund Existence11 years12 years-
Gain YTD18.51920.66090%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets7.92B3.78B210%
Annual Yield % from dividends6.162.74225%
Returns for 1 year25.8428.5491%
Returns for 3 years77.9194.6082%
Returns for 5 years79.1589.0289%
Returns for 10 years133.26139.4696%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSPFX32.35-0.14
-0.43%
Victory RS Partners A
AMAGX106.43-0.84
-0.78%
Amana Growth Investor
GRMAX34.06-0.29
-0.84%
Nationwide S&P 500 Index A
TNRAX22.97-0.21
-0.89%
1290 Avantis U.S. Large Cap Growth A
SHPCX15.50-0.26
-1.65%
Saratoga Health & Biotechnology C